Murphy Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $5M | Sell |
15,432
-490
| -3% | -$147K | 0.69% | 42 |
|
|
2022
Q1 | $4.56M | Sell |
15,922
-355
| -2% | -$91.4K | 0.53% | 50 |
|
|
2021
Q4 | $4.5M | Sell |
16,277
-532
| -3% | -$135K | 0.48% | 54 |
|
|
2021
Q3 | $3.88M | Sell |
16,809
-105
| -0.6% | -$25.9K | 0.45% | 54 |
|
|
2021
Q2 | $3.88M | Sell |
16,914
-140
| -0.8% | -$28.1K | 0.44% | 54 |
|
|
2021
Q1 | $3.19M | Buy |
17,054
+87
| +0.5% | +$17K | 0.4% | 60 |
|
|
2020
Q4 | $2.86M | Sell |
16,967
-1,105
| -6% | -$165K | 0.38% | 60 |
|
|
2020
Q3 | $2.67M | Buy |
18,072
+609
| +3% | +$94.3K | 0.39% | 62 |
|
|
2020
Q2 | $2.87M | Sell |
17,463
-150
| -0.9% | -$23K | 0.45% | 56 |
|
|
2020
Q1 | $2.44M | Sell |
17,613
-1,690
| -9% | -$232K | 0.46% | 57 |
|
|
2019
Q4 | $2.54M | Sell |
19,303
-87
| -0.4% | -$10.1K | 0.36% | 68 |
|
|
2019
Q3 | $2.17M | Sell |
19,390
-245
| -1% | -$27.3K | 0.33% | 76 |
|
|
2019
Q2 | $2.17M | Buy |
19,635
+2,591
| +15% | +$305K | 0.32% | 79 |
|
|
2019
Q1 | $2.21M | Sell |
17,044
-773
| -4% | -$94K | 0.34% | 74 |
|
|
2018
Q4 | $2.06M | Buy |
17,817
+595
| +3% | +$66.5K | 0.35% | 76 |
|
|
2018
Q3 | $1.85M | Sell |
17,222
-995
| -5% | -$99.5K | 0.26% | 94 |
|
|
2018
Q2 | $1.55M | Sell |
18,217
-565
| -3% | -$46.4K | 0.22% | 108 |
|
|
2018
Q1 | $1.45M | Sell |
18,782
-734
| -4% | -$59.1K | 0.21% | 112 |
|
|
2017
Q4 | $1.65M | Sell |
19,516
-70
| -0.4% | -$5.96K | 0.23% | 107 |
|
|
2017
Q3 | $1.68M | Buy |
19,586
+120
| +0.6% | +$9.84K | 0.24% | 103 |
|
|
2017
Q2 | $1.6M | Sell |
19,466
-605
| -3% | -$49.4K | 0.24% | 102 |
|
|
2017
Q1 | $1.69M | Sell |
20,071
-313
| -2% | -$25.1K | 0.25% | 98 |
|
|
2016
Q4 | $1.5M | Buy |
20,384
+5,425
| +36% | +$404K | 0.24% | 103 |
|
|
2016
Q3 | $1.2M | Buy |
14,959
+400
| +3% | +$32K | 0.19% | 114 |
|
|
2016
Q2 | $1.15M | Sell |
14,559
-1,100
| -7% | -$82.8K | 0.18% | 121 |
|
|
2016
Q1 | $1.13M | Sell |
15,659
-2,300
| -13% | -$174K | 0.18% | 121 |
|
|
2015
Q4 | $1.51M | Buy |
17,959
+3,420
| +24% | +$284K | 0.23% | 101 |
|
|
2015
Q3 | $1.22M | Buy |
14,539
+8,740
| +151% | +$738K | 0.2% | 117 |
|
|
2015
Q2 | $484K | Sell |
5,799
-150
| -3% | -$11.4K | 0.07% | 213 |
|
|
2015
Q1 | $432K | Buy |
5,949
+100
| +2% | +$7.12K | 0.06% | 220 |
|
|
2014
Q4 | $403K | Sell |
5,849
-930
| -14% | -$62.8K | 0.06% | 229 |
|
|
2014
Q3 | $439K | Buy |
6,779
+1,600
| +31% | +$101K | 0.07% | 222 |
|
|
2014
Q2 | $321K | Sell |
5,179
-11
| -0.2% | -$656 | 0.05% | 257 |
|
|
2014
Q1 | $305K | Hold |
5,190
| – | – | 0.05% | 274 |
|
|
2013
Q4 | $264K | Sell |
5,190
-415
| -7% | -$20.8K | 0.05% | 268 |
|
|
2013
Q3 | $282K | Sell |
5,605
-125
| -2% | -$6.54K | 0.05% | 251 |
|
|
2013
Q2 | $281K | Buy |
+5,730
| New | +$312K | 0.06% | 240 |
|
Other funds holding LLY
Murphy Capital Management's LLY Position: Q2 2022 in Review
Murphy Capital Management reduced its Eli Lilly (LLY) stake by 3.1% in Q2 2022, selling an estimated $147K and leaving 15,432 shares worth $5M. The position accounts for 0.69% of the portfolio, ranked #42.
Murphy Capital Management first reported a position in LLY in Q2 2013 and has held it in 37 quarters since. 2,445 funds tracked by Wall St. Rank hold LLY as of Q2 2022.
- Murphy Capital Management held 15,432 shares of Eli Lilly worth $5M as of Q2 2022.
- Murphy Capital Management sold 490 Eli Lilly shares in Q2 2022, an estimated $147K.
- Eli Lilly made up 0.69% of Murphy Capital Management's portfolio in Q2 2022, its #42 holding.
- Murphy Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 37 quarters since.
- 2,445 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2022.
Based on Murphy Capital Management's 13F filing for Q2 2022, filed 13 Jul 2022.